Literature DB >> 30342991

MicroRNA-23a promotes colorectal cancer cell survival by targeting PDK4.

Yi Hui Deng1, Zhi Hui Deng2, Hu Hao3, Xian Lin Wu1, Hui Gao1, Shao Hui Tang1, Hui Tang4.   

Abstract

MicroRNA (miR) is important regulators of gene expression, and aberrant miR expression has been linked to oncogenesis; however, little is understood about their contribution to colorectal cancer (CRC). Here, we determined that miR-23a is overexpressed in human colorectal cancer cell lines and tissues compared with that of normal cells. The stable over-expression of miR-23a in CRC cells was sufficient to promote cell proliferation in vitro and in vivo. Further studies showed that miR-23a can directly bind to the 3'untranslated region (3'UTR) of PDK4 mRNA and subsequently repress both the mRNA and protein expressions of PDK4. PDK4 negatively regulate CRC proliferation via suppressing PDH activity. Ectopic expression of PDK4 by transiently transfected with PDK4 vector encoding the entire coding sequence could reverse the effects of miR-23a on CRC proliferation. By this way, miR-23a promotes PDH activation and oxidative phosphorylation to generate sufficient ATP for cell proliferation. Our results illustrated that the up-regulation of miR-23a played an important role in CRC cell proliferation through direct repressing PDK4, suggesting a potential application of miR-23a in prognosis prediction and therapeutic application in CRC.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; MiR-23a; Oxidative phosphorylation; PDK4; Proliferation

Mesh:

Substances:

Year:  2018        PMID: 30342991     DOI: 10.1016/j.yexcr.2018.10.010

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  MiR-122-5p suppresses neuropathic pain development by targeting PDK4.

Authors:  Lanlan Wan; Zhen Su; Fayin Li; Pengfei Gao; Xianlong Zhang
Journal:  Neurochem Res       Date:  2021-02-10       Impact factor: 3.996

2.  Long non-coding RNA LINC00243 promotes proliferation and glycolysis in non-small cell lung cancer cells by positively regulating PDK4 through sponging miR-507.

Authors:  Xuegang Feng; Shengsheng Yang
Journal:  Mol Cell Biochem       Date:  2019-10-08       Impact factor: 3.396

3.  The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment.

Authors:  Erez Uzuner; Gizem Tugçe Ulu; Sevim Beyza Gürler; Yusuf Baran
Journal:  Methods Mol Biol       Date:  2022

4.  Diagnostic and prognostic value of microRNA-193b in patients with glioma and its effect on tumor progression.

Authors:  Mingtao Zhu; Wei Zhao; Hui Zhao; Jing Zhang
Journal:  Oncol Lett       Date:  2019-09-06       Impact factor: 2.967

5.  Molecular Insights into miRNA-Driven Resistance to 5-Fluorouracil and Oxaliplatin Chemotherapy: miR-23b Modulates the Epithelial–Mesenchymal Transition of Colorectal Cancer Cells

Authors:  Stasė Gasiulė; Nadezda Dreize; Algirdas Kaupinis; Raimundas Ražanskas; Laurynas Čiupas; Vaidotas Stankevičius; Žana Kapustina; Arvydas Laurinavičius; Mindaugas Valius; Giedrius Vilkaitis
Journal:  J Clin Med       Date:  2019-12-02       Impact factor: 4.241

6.  Toosendanin induces apoptosis of MKN‑45 human gastric cancer cells partly through miR‑23a‑3p‑mediated downregulation of BCL2.

Authors:  Shuli Shao; Shanshan Li; Chang Liu; Weiwei Zhang; Zhenzhu Zhang; Shaowei Zhu; Yunjianan Feng; Yang Pan
Journal:  Mol Med Rep       Date:  2020-06-22       Impact factor: 2.952

Review 7.  MicroRNA, Diabetes Mellitus and Colorectal Cancer.

Authors:  Hsiuying Wang
Journal:  Biomedicines       Date:  2020-11-24

8.  CREB1-induced miR-1204 promoted malignant phenotype of glioblastoma through targeting NR3C2.

Authors:  Xinli Zhao; Fazheng Shen; Jiwei Ma; Shupeng Zhao; Lei Meng; Xiangyang Wang; Shufeng Liang; Jianing Liang; Chaoshuai Hu; Xinzhong Zhang
Journal:  Cancer Cell Int       Date:  2020-04-07       Impact factor: 5.722

9.  Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer.

Authors:  Danuta Sastre; João Baiochi; Ildercilio Mota de Souza Lima; Felipe Canto de Souza; Amanda Cristina Corveloni; Carolina Hassib Thomé; Vitor Marcel Faça; Josiane Lilian Dos Santos Schiavinato; Dimas Tadeu Covas; Rodrigo Alexandre Panepucci
Journal:  BMC Cancer       Date:  2019-12-21       Impact factor: 4.430

10.  Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases.

Authors:  Esther P Jane; Daniel R Premkumar; Dhivyaa Rajasundaram; Swetha Thambireddy; Matthew C Reslink; Sameer Agnihotri; Ian F Pollack
Journal:  Mol Oncol       Date:  2021-06-23       Impact factor: 6.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.